Extended Data Fig. 2: iCat Recommendations.
From: Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Number of genes with iCat recommendations per patient at the time of initial report (February, 2016 to June, 2019) and with updated evidence reviewed between May and June, 2020 (a). Highest tier of iCat therapeutic recommendation for each patient at the time of initial report (February, 2016 to June, 2019) and with updated evidence reviewed between May and June, 2020 (b).
